Concepedia

Hansen Op

HO

Statistics

Publications

2

Citations

84

H-Index

2

Active since

1991

Affiliations

Rigshospitalet(Current)

Hansen Op is an author at Rigshospitalet specializing in hematologic malignancy therapy, chemotherapy, and acute leukemias.

Publications per year

1991–1997

2

Publications

2

Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.

Hansen Op, J Pedersen-Bjergaard, J Ellegaard et al. · PubMed · 1991 · 71 citations

, , +15

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

Peter de Nully Brown, T Hoffmann, Hansen Op et al. · Leukemia · 1997 · 13 citations

, , +17

1–2 of 2